Compounds > tanshinone
Page last updated: 2024-09-02

tanshinone and Cardiac Diseases

tanshinone has been researched along with Cardiac Diseases in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, SJ1
Guan, S; Guo, DA; Jiang, B; Li, M; Liu, X; Wang, J; Wang, Y; Wu, W; Yang, M; Zhang, L1
Bao, Y; Fang, J; Gao, J; Liu, P; Mou, YG; Pi, R; Wang, P; Wu, X; Zhou, S1

Other Studies

3 other study(ies) available for tanshinone and Cardiac Diseases

ArticleYear
Drug-target networks for Tanshinone IIA identified by data mining.
    Chinese journal of natural medicines, 2015, Volume: 13, Issue:10

    Topics: Abietanes; Data Mining; Drugs, Chinese Herbal; Heart Diseases; Humans; Pharmacology; Phytotherapy; Proteins; Salvia miltiorrhiza

2015
Tanshinone IIA sodium sulfonate protects against cardiotoxicity induced by doxorubicin in vitro and in vivo.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2009, Volume: 47, Issue:7

    Topics: Abietanes; Animals; Antibiotics, Antineoplastic; Benzimidazoles; Cardiotonic Agents; Cell Line; Doxorubicin; Electrocardiography; Fibrillar Collagens; Fluorescent Dyes; Heart; Heart Diseases; Male; Mice; Myoblasts; Phenanthrenes; Rats; Tensile Strength

2009
Tanshinone IIA prevents cardiac remodeling through attenuating NAD (P)H oxidase-derived reactive oxygen species production in hypertensive rats.
    Die Pharmazie, 2011, Volume: 66, Issue:7

    Topics: Abietanes; Animals; Blotting, Western; Cardiomegaly; Cardiotonic Agents; Coronary Circulation; Enzyme Inhibitors; Fibrosis; Heart Diseases; Hemodynamics; Hypertension, Renovascular; Male; Myocardium; NADPH Oxidases; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; Stroke Volume; Ultrasonography; Ventricular Dysfunction, Left

2011